secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0000950170-23-017910
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q1 revenue $59.2M (+18% YoY); net loss $15.6M
-------------------------------------------------------------------

- Revenue $59.2M (+18% YoY from $50.1M); net loss $15.6M vs $13.1M prior year.
- Adjusted net income $9.2M, up from $7.7M; adjusted EBITDA $15.7M (26% of revenue).
- Q2 2023 guidance: revenue $60.5-$61.5M; full-year 2023 rev $249-255M (+12-15% YoY).
- Launched DefinitiveConnect for Salesforce integration and Atlas AI analytics suite.
- Enterprise customers: 529 with >$100K ARR; won deals with pharma, hospital, and non-profit clients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023017910/0000950170-23-017910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023017910/dh-20230504.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-017910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer